Loading...
JS BANK LTD. — Imatinib Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #7 buyer for Imatinib · $407.8K import value · 17 shipments · PAKISTAN · DGFT Verified
JS BANK LTD. is the #7 importer of Imatinib from India with $407.8K in import value and 17 verified shipments. JS BANK LTD. holds a 2.9% market share in Imatinib imports based in PAKISTAN. The company sources from 1 verified supplier across 7 formulations shipped to 1 country.
Verified from 17 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $407.8K | 17 | 100.0% |
JS BANK LTD. sources Imatinib from 1 verified Indian supplier based on 17 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #7 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $1.5M | 30 | $50.0K |
| 7 | JS BANK LTD. ★ | PAKISTAN | $850.0K | 17 | $50.0K |
| 2 | COOPER PHARMA | MOROCCO | $800.0K | 16 | $50.0K |
| 6 | HABIB BANK LIMITED | PAKISTAN | $750.0K | 15 | $50.0K |
JS BANK LTD. ranks #7 among 456 Imatinib importers from India. Average shipment value of $50.0K compared to the market average of $19.3K. The closest competitors by value are AUROLOGISTICS LLC, (AUROBINDO PHARM and COOPER PHARMA.
Destination countries from 17 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| PAKISTAN | $407.8K | 17 | 100.0% |
JS BANK LTD. imports Imatinib to 1 country. The primary destination is PAKISTAN receiving 100.0% of shipments worth $407.8K.
| Formulation | Value | Shipments |
|---|---|---|
| IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG ) INV.QTY.23710 PACK 1X10'S=237100 NOS | $73.0K | 3 |
| IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG ) INV.QTY.23590 PACK 1X10'S=235900 NOS | $72.7K | 3 |
| IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG ) INV.QTY.23550 PACK 1X10'S=235500 NOS | $72.5K | 3 |
| IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG ) INV.QTY.23410 PACK 1X10'S=234100 NOS | $72.1K | 3 |
| IMATIB ALPHA 100 CAPSULES (IMATINIB CAPSULES 100 MG) (11970 PACKX1X10'S=119700 NOS) | $50.0K | 1 |
| IMATIB ALPHA 100 CAPSULES (IMATINIB CAPSULES 100MG) (1X10'S X11880PACK=118800NUM) | $50.0K | 1 |
| IMATIB ALPHA 100 CAPSULES ( IMATINIB CAPSULES 100 MG ) INV.QTY.5670PACK 1X10'S=56700 NOS | $17.5K | 3 |
JS BANK LTD. imports from India.
India exported $8.8M worth of Imatinib through 1,726 shipments from 224 suppliers to 119 countries, serving 456 buyers globally. JS BANK LTD. imports $407.8K of this total, accounting for 2.9% of India's Imatinib exports with 17 shipments from PAKISTAN. This is verified from 17 customs shipment records covering 7 distinct formulations.
JS BANK LTD.'s average Imatinib order value is $24.0K per consignment, based on 17 shipments totaling $407.8K. JS BANK LTD. is based in PAKISTAN and ranks #7 among all Imatinib importers from India by value. The company sources from 1 verified supplier in India.
JS BANK LTD. sources Imatinib from 1 verified Indian supplier: CIPLA LIMITED ($407.8K, 100.0%). This is based on 17 customs records.
JS BANK LTD. ranks #7 among 456 Imatinib importers from India with a 2.9% market share. The top 3 importers are AUROLOGISTICS LLC, (AUROBINDO PHARM ($1.5M), JS BANK LTD. ($850.0K), COOPER PHARMA ($800.0K). JS BANK LTD. processed 17 shipments from PAKISTAN.
Latest developments and market context
Detailed market intelligence for Imatinib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for JS BANK LTD.'s Imatinib imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
JS BANK LTD.
Company Profile
Multiple products · $0 total trade · Multiple categories
Verified from customs records
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 119+ countries, 456+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for JS BANK LTD..
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Imatinib. For current order-level data, contact TransData Nexus.